Related Experiment Video
Updated: Jan 28, 2026
Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
Atrial fibrillation and stroke: a practical guide
Jonathan Gordon Best1, Robert Bell2, Mohammed Haque3
1Stroke Research Centre, University College London Queen Square Institute of Neurology, London, UK.
Insights
Atrial fibrillation increases stroke risk, but anticoagulation decisions are complex. New direct oral anticoagulants offer improved stroke prevention but require careful management to balance bleeding risks.
Area of Science:
- Cardiology
- Neurology
- Pharmacology
Background:
- Atrial fibrillation is a primary cause of ischemic stroke.
- Anticoagulation is crucial for preventing cardioembolic stroke.
- Balancing stroke risk and bleeding risk (especially intracranial hemorrhage) complicates anticoagulation decisions.
Purpose of the Study:
- To provide an overview of current atrial fibrillation diagnosis and management.
- To discuss the evidence base for anticoagulation in atrial fibrillation.
- To highlight challenges and future directions in atrial fibrillation care.
Main Methods:
- Review of contemporary diagnosis and management strategies for atrial fibrillation.
- Analysis of the evidence base supporting anticoagulation therapies.
- Discussion of clinical decision-making in anticoagulation therapy.
Main Results:
- Direct oral anticoagulants (DOACs) have become widely available, improving stroke care.
- DOACs present new challenges in managing atrial fibrillation patients.
- Interdisciplinary collaboration is essential for effective atrial fibrillation management.
Conclusions:
- Contemporary management of atrial fibrillation requires balancing stroke and bleeding risks.
- Advances in anticoagulation, particularly DOACs, necessitate updated clinical approaches.
- Ongoing research is vital for refining future atrial fibrillation treatment strategies.
Abstract:
Neurologists and stroke physicians will be familiar with atrial fibrillation as a major cause of ischaemic stroke, and the role of anticoagulation in preventing cardioembolic stroke. However, making decisions about anticoagulation for individual patients remains a difficult area of clinical practice, balancing the serious risk of ischaemic stroke against that of major bleeding, particularly intracranial haemorrhage. Atrial fibrillation management requires interdisciplinary collaboration with colleagues in cardiology and haematology. Recent advances, especially the now-widespread availability of direct oral anticoagulants, have brought opportunities to improve stroke care while posing new challenges. This article gives an overview of the contemporary diagnosis and management of atrial fibrillation, and the associated evidence base. Where there is uncertainty, we describe our own approach to these areas, while highlighting ongoing research that will likely guide future practice.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
03:03Amyloid Fibrils
01:11Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
01:16Characteristics of Practical Op Amps
The ratio of differential gain to the common-mode gain is defined as the common-mode rejection ratio (CMRR). This ratio quantifies the ability of operational amplifiers (op-amps) to reject common-mode...
01:30Theoretical Foundations of Nursing Practice
Theories provide a perspective to assess patients' conditions and organize data and methods. They also assist in analyzing and interpreting information. They represent a...
01:28Equivalent Circuits for Practical Transformers
In a practical transformer, each winding exhibits resistance and leakage reactance. The...